Jyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, Amit Joshi, Vijay Patil, Vanita Noronha, . . . Vikram Gota. (2021). Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy. SAGE Publishing.
Chicago Style (17th ed.) CitationJyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, Amit Joshi, Vijay Patil, Vanita Noronha, Kumar Prabhash, and Vikram Gota. Validation of a Novel Causality Assessment Scale for Adverse Events in Non-small Cell Lung Carcinoma Patients Treated with Platinum and Pemetrexed Doublet Chemotherapy. SAGE Publishing, 2021.
MLA (9th ed.) CitationJyoti Bhagatram Sharma, et al. Validation of a Novel Causality Assessment Scale for Adverse Events in Non-small Cell Lung Carcinoma Patients Treated with Platinum and Pemetrexed Doublet Chemotherapy. SAGE Publishing, 2021.